| Phase 4 |
| NCT07600164 |
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer |
HER2 + Breast Cancer |
Recruiting |
2026-07-13 |
| NCT07824713 |
ED50/ED90 of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension… |
Hypotension After Spinal Anesthesia |
Not Yet Recruiting |
2026-09-17 |
| NCT06364319 |
Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD |
cGVHD |
Not Yet Recruiting |
2026-06-18 |
| NCT07075250 |
Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With… |
Platinum-resistant Ovarian Cancer (PROC) |
Not Yet Recruiting |
2025-07-20 |
| Phase 3 |
| NCT07441291 |
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT |
B ALL |
Recruiting |
2026-02-27 |
| NCT05921305 |
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD |
Acute Graft Versus Host Disease |
Recruiting |
2025-06-03 |
| NCT06802718 |
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia |
Acute Myeloid Leukemia |
Recruiting |
2025-01-31 |
| NCT07737262 |
Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in… |
Aplastic Anemia |
Not Yet Recruiting |
2026-09-16 |
| NCT07597395 |
ATRA for Management of Primary ITP |
Immune Thrombocytopenia |
Not Yet Recruiting |
2026-05-19 |
| NCT07407660 |
Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in… |
Acute Myeloid Leukemia |
Not Yet Recruiting |
2026-02-12 |
| Phase 2/3 |
| NCT06879379 |
KPD Consolidation After ASCT in NDMM Patients |
Multiple Myeloma, Newly Diagnosed |
Recruiting |
2025-03-17 |
| NCT06202625 |
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT |
Thrombocytopenia |
Recruiting |
2024-10-01 |
| NCT03793517 |
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT |
Stem Cell Transplant Complications |
Recruiting |
2020-03-10 |
| Phase 2 |
| NCT07677306 |
Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT |
Myelodysplastic Syndromes |
Recruiting |
2026-09-16 |
| NCT07796516 |
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis |
Difficult-to-treat Rheumatoid Arthritis |
Recruiting |
2026-09-01 |
| NCT07335887 |
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With… |
AL Amyloidosis (AL) |
Recruiting |
2026-07-28 |
| NCT05576389 |
Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA… |
Germline BRCA-mutated HER2-negative Breast Cancer |
Recruiting |
2026-07-21 |
| NCT06970912 |
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in… |
Hormone Receptor-Positive Breast Cancer |
Recruiting |
2026-07-13 |
| NCT07366112 |
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment |
Hormone Receptor-Positive Breast Cancer |
Recruiting |
2026-07-13 |
| NCT07586813 |
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… |
Persistent Isolated Chemotherapy-Induced Thrombocytopenia |
Recruiting |
2026-05-14 |
| NCT07586826 |
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… |
Persistent Isolated Chemotherapy-Induced Thrombocytopenia |
Recruiting |
2026-05-14 |
| NCT07065968 |
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly… |
Immune Thrombocytopenia (ITP) |
Recruiting |
2025-09-08 |
| NCT06984536 |
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT |
Myelodysplastic Syndrome |
Recruiting |
2025-07-25 |
| NCT06130579 |
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT |
Myeloid Leukemia |
Recruiting |
2025-06-03 |
| NCT06869265 |
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical… |
Acute Myeloid Leukemia (AML) |
Recruiting |
2025-05-18 |